World's Best Scientists 2026 revealed!
Scott A. Halperin

Scott A. Halperin

D-Index & Metrics

Immunology

D-Index
81
Citations
22785
World Ranking
1576
National Ranking
29

Medicine

D-Index
81
Citations
22858
World Ranking
16706
National Ranking
700

Scott A. Halperin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Scott A. Halperin sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 455 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Scott A. Halperin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Scott A. Halperin sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Scott A. Halperin is affiliated with Dalhousie University in Canada and has contributed extensively to research in the field of medicine, with a specific focus on epidemiology, infectious diseases, health, microbiology, and general health professions. Their work spans a wide range of topics including vaccine coverage and hesitancy, influenza virus research, respiratory viral infections, bacterial infections and vaccines, pneumonia and respiratory infections, SARS-CoV-2 and COVID-19 research, and viral gastroenteritis research and epidemiology.

Halperin's most recent publications include significant contributions to the understanding of respiratory and viral infections. Notable papers include:

  • "COVID-19 in children: the link in the transmission chain" (2020, The Lancet Infectious Diseases)
  • "Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial" (2021, The Lancet)
  • "Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons" (2024, Clinical Infectious Diseases)
  • "Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances" (2023, Environment International)
  • "Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study" (2023, The Lancet Regional Health - Americas)

The frequent coauthors who have collaborated with Scott A. Halperin throughout their research career include:

  • Manish Sadarangani
  • Julie A. Bettinger
  • Shaun K. Morris
  • Karina A. Top
  • Joanne M. Langley

The researcher has published predominantly in several venues known for their focus on immunization and public health, including:

  • Vaccine (22 publications)
  • Human Vaccines & Immunotherapeutics (9 publications)
  • PLoS ONE (6 publications)
  • Open Forum Infectious Diseases (4 publications)
  • CMAJ Open (4 publications)

Scott A. Halperin's body of work integrates considerations from vaccine effectiveness, safety, epidemiological modeling, and public health impact. Their research addresses both pediatric and adult populations and engages with current public health challenges such as COVID-19 and respiratory syncytial virus. The combined focus on immunology, infectious diseases, and epidemiology highlights cross-disciplinary approaches essential for disease prevention and control.

Best Publications

  • Transmission of Bordetella pertussis to young infants

    Aaron M. Wendelboe;Elisabeth Njamkepo;Antoine Bourillon;D. Daniel Floret

  • Pertussis of adults and infants.

    CH Wirsing von König;S Halperin;M Riffelmann;N Guiso

  • Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

    Simon R. M. Dobson;Shelly McNeil;Marc Dionne;Meena Dawar

  • Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline (summary)

    Anna Taddio;Mary Appleton;Robert Bortolussi;Christine Chambers

  • Morbidity of Pertussis in Adolescents and Adults

    Gaston De Serres;Ramak Shadmani;Bernard Duval;Nicole Boulianne

  • The changing and dynamic epidemiology of meningococcal disease.

    Scott A. Halperin;Julie A. Bettinger;Brian Greenwood;Lee H. Harrison

  • Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers

    Shelly A. McNeil;Scott A. Halperin;Joanne M. Langley;Bruce Smith

  • Inadequate pain management during routine childhood immunizations: the nerve of it.

    Anna Taddio;Christine T. Chambers;Christine T. Chambers;Scott A. Halperin;Moshe Ipp

  • Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

    Unknown

  • Reducing pain during vaccine injections: clinical practice guideline.

    Anna Taddio;C. Meghan McMurtry;Vibhuti Shah;Rebecca Pillai Riddell

  • COVID-19 in children: the link in the transmission chain.

    Alyson A Kelvin;Alyson A Kelvin;Scott Halperin

  • A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant☆

    Scott A Halperin;Gary Van Nest;Bruce Smith;Simin Abtahi

  • Pertussis Is a Frequent Cause of Prolonged Cough Illness in Adults and Adolescents

    Linda D. Senzilet;Scott A. Halperin;John S. Spika;Merrilyn Alagaratnam

  • Induction of Immunologic Memory by Conjugated vs Plain Meningococcal C Polysaccharide Vaccine in Toddlers: A Randomized Controlled Trial

    Noni E. MacDonald;Scott A. Halperin;Barbara J. Law;Bruce Forrest

  • Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

    Matthew D. Snape;Kirsten P. Perrett;Karen J. Ford;Tessa M. John

  • Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013.

    Tina Quanbee Tan;Tine Dalby;Kevin Forsyth;Scott A. Halperin

  • The changing age and seasonal profile of pertussis in Canada

    Danuta M. Skowronski;Gaston De Serres;Diane MacDonald;Diane MacDonald;Wrency Wu

  • Cost of Chickenpox in Canada: Part I. Cost of Uncomplicated Cases

    Barbara Law;Catherine Fitzsimon;Lee Ford-Jones;Noni MacDonald

  • Epidemiological Features of Pertussis in Hospitalized Patients in Canada, 1991- 1997: Report of the Immunization Monitoring Program—Active (IMPACT)

    Scott A. Halperin;Elaine E. L. Wang;Barbara Law;Elaine Mills

  • Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration.

    M. Campins-Martí;H. K. Cheng;K. Forsyth;N. Guiso

  • Kinetics of the Antibody Response to Tetanus-Diphtheria-Acellular Pertussis Vaccine in Women of Childbearing Age and Postpartum Women

    B. A. Halperin;A. Morris;D. MacKinnon-Cameron;J. Mutch

Frequent Co-Authors

David W. Scheifele
David W. Scheifele University of British Columbia
Shelly A. McNeil
Shelly A. McNeil Dalhousie University
Brian J. Ward
Brian J. Ward McGill University Health Centre
Noni MacDonald
Noni MacDonald Dalhousie University
Gaston De Serres
Gaston De Serres Université Laval
Natasha S. Crowcroft
Natasha S. Crowcroft University of Toronto
Marc Dionne
Marc Dionne Université Laval
Christine T. Chambers
Christine T. Chambers Dalhousie University
Volker Gerdts
Volker Gerdts University of Saskatchewan
Allison McGeer
Allison McGeer University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in exploring career options tied to Immunology, nursing pathways offer valuable opportunities. Many students seek programs that balance quality education with manageable admission criteria. For example, lpn programs with easiest admission requirements provide a practical entry point into healthcare professions, especially for those looking to gain clinical experience quickly.

Advancing further, students might consider becoming nurse practitioners. Programs like nurse practitioner programs with easy admission highlight institutions where entry barriers are lower without compromising educational standards, easing the path toward advanced practice roles in immunology-related fields.

Specializing within mental health can be another rewarding direction. The best pmhnp programs online focus on psychiatric mental health nurse practitioner training, ensuring excellent clinical placement opportunities vital for hands-on experience in patient care.

Cost is always a consideration, so it is beneficial to explore affordable pmhnp programs that maintain quality while making education more accessible. These pathways collectively support diverse career goals tied to immunology and healthcare.

Best Scientists Citing Scott A. Halperin

Trending Scientists

Recently Published Articles